Absurdity Audit: UBS AT1 Return
Finding 1 – Market Timing: A bank raises $1.5 billion in the riskiest slice of capital the exact moment regulators in Switzerland hit pause on stricter oversight. This is the financial version of scheduling your annual physical the day after the doctor cancels bloodwork.
Finding 2 – Product Choice: Additional tier 1 bonds sit at the bottom of the loss pile during any real stress test. Issuing them now reads less like prudent funding and more like testing how far the new leniency actually stretches before something snaps.
Verdict: The pause did not slow capital raising; it simply removed the inconvenience of higher standards, letting the same high-risk product re-enter the market with less resistance than before.
